Neoadjuvant therapy in surgical oncology refers to treatment given:
-
A
After surgery to eliminate residual disease
-
B
Before surgery to downstage tumors and improve resectability
-
C
During surgery as intraoperative chemotherapy
-
D
Only to patients who are not surgical candidates